Back to Search Results
Interim Chair of the Department of Medicine
Professor of Medicine
Professor of Health Policy and Management (Secondary)
Office Phone: 202-741-2233
- BA, University of Pennsylvania, 1996
- MD, Johns Hopkins University, 2001
- MBA, University of Chicago, 2005
Dr. William Borden is the Interim Chair of Medicine and Professor of Medicine and Health Policy and Management at the George Washington University, and the Chief Quality and Population Health Officer at the GW Medical Faculty Associates. Dr. Borden leads the Department of Medicine, as well as the physician organization’s quality and population health management programs focused on delivering high-quality, appropriate, patient-centered care. He is a practicing cardiologist specializing in preventive cardiology and lipidology.
Dr. Borden previously served as a Senior Advisor to the Assistant Secretary for Planning and Evaluation at the US Department of Health and Human Services and as a Medical Officer at the Agency for Healthcare Research and Quality. His research focuses on policy approaches to improving quality of care and has been published in journals such as JAMA, JAMA Internal Medicine, Circulation, and the Journal of the American College of Cardiology. Dr. Borden is a member of the Medicare Evidence Development & Coverage Advisory Committee, the Health Care Payment Learning & Action Network, and the American College of Cardiology’s Population Health Management Task Force. He previously served as Chair of the American Heart Association’s Quality of Care and Outcomes Research Council.
TrainingInternal Medicine Residency:
- University of Chicago, 2004
- Chief Medical Resident, University of Chicago, 2005
- University of Chicago, 2008
- Preventive cardiology
- Clinical lipidology
- General cardiology
- Health policy
Dr. Borden’s research focuses on policy approaches to improving quality of care, including the impact of hospital value-based purchasing on socioeconomically disadvantaged hospitals, the dissemination and clinical update of patient-centered outcomes research, and how population health can best be implemented.
- Impact of Policy on Health Care Organizations. Substance Abuse and Mental Health Services Agency. U.S. Department of Health and Human Services.
- Advancing Data Science and Methods for Healthcare Delivery Transformation. Guest-guided discussion. National Library of Medicine Health Services Research Information Advisory Committee. Washington, DC
- MACRA: The Perspective of the Practicing Cardiology. American College of Cardiology Scientific Sessions 2017.
- The Future of Health Policy, Co-Chair. The American Heart Association Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke
Dr. Borden has served as the medical director of a free heart disease screening clinic in medically underserved areas. He serves on the editorial boards of Circulation: Cardiovascular Quality and Outcomes, and Current Atherosclerosis Reports
- Member, Health Care Payment Learning and Action Network
- Member, Medicare Evidence Development & Coverage Advisory Committee (MEDCAC)
- Member, American College of Cardiology Population Health Management Task Force
- Prior Chair, American Heart Association Council on Quality of Care & Outcomes Research
- Member, American Heart Association Council on Quality of Care & Outcomes Research Leadership Committee
Sandhu AT, Heidenreich PA, Borden W, Farmer SA, Ho MP, Hammond G, Johnson JC, Wadhera RK, Wasfy JH, Biga C, Takahashi E, Misra KD, Joynt Maddox KE and on behalf of the American Heart Association Advocacy Coordinating Committee. Value-Based Payment for Clinicians Treating Cardiovascular Disease: A Policy Statement From the American Heart Association. Circulation. 2023;147:e00–e00. DOI: 10.1161/CIR.0000000000001143. Epub 2023 Jul 10.
Kini V, Breathett K, Groeneveld PW, Ho PM, Nallamothu BK, Peterson PN, Rush P, Wang TY, Zeitler EP, Borden WB. Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2022 Mar;15(3):e000105. doi: 10.1161/HCQ.0000000000000105. Epub 2022 Feb 22.
Borden WB, Wang J, Jones P, Tang Y, Contreras J, Daugherty SL, Desai NR, Virani SS, Wasfy JH, Maddox TM. Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2022 Mar 11;CIRCOUTCOMES121007908.
CV-Quic Collaborators, Bradley SM, Adusumalli S, Amin, AP, Borden WB, Das SR, Downey WE, Ebinger JE, Gelbman J, Gluckman TJ, Goyal A, Gupta D, Knot UN, Levy AE, Mutharasan RK, Rush P, Strauss CE, Shreenivas S, Ho PM. The Cardiovascular Quality Improvement and Care Innovation Consortium: Inception of a Multicenter Collaborative to Improve Cardiovascular Care. Circ Cardiovasc Qual Outcomes. 2021 Jan;14(1):e006753. doi: 10.1161/CIRCOUTCOMES.120.006753. Epub 2021 Jan 12. PMID: 33430610
Kauffman DM, Borden WB, Choi BG. Maximizing Performance in Medicare’s Merit Based Incentive Payment System: A Financial Model to Optimize Health Information Technology Resource Allocation. Inquiry. 2020 Jan-Dec;57:46958020971237. doi: 10.1177/0046958020971237. PMID: 33174501
Critique and Review: Borden WB, Making Health Policy More Accessible, Circulation: Cardiovascular Quality and Outcomes, 2018 Dec
Critique and Review: Borden WB, Optimizing Transparency to Empower Patients, Circulation: Cardiovascular Quality and Outcomes, 2018 May
Pokharel Y, Tang F, Jones PG, Nambi V, Bittner VA, Hira RS, Nasir K, Chan PS, Maddox TM, Oetgen WJ, Heidenreich PA, Borden WB, Spertus JA, Petersen LA, Ballantyne CM, Virani SS. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017 Mar 1.
Okunrintemi V, Spatz ES, Di Capua P, Salami JA, Valero-Elizondo J, Warraich H, Virani SS, Blaha MJ, Blankstein R, Butt AA, Borden WB, Dharmarajan K, Ting H, Krumholz HM, Nasir K. Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013. Circ Cardiovasc Qual Outcomes. 2017 Apr 10.
Maddox TM, Albert NM, Borden WB, Curtis LH, Ferguson TB Jr, Kao DP, Marcus GM, Peterson ED, Redberg R, Rumsfeld JS, Shah ND, Tcheng JE. The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association. Circulation. 2017 Apr 4.
Borden WB, Dickson VV. Care Innovation: Sharing Practical Care Delivery Tools and Discoveries. Circ Cardiovasc Qual Outcomes. 2017 June 10.
Okunrintemi V, Spatz ES, Di Capua P, Salami JA, Valero-Elizondo J, Warraich H, Virani SS, Blaha MJ, Blankstein R, Butt AA, Borden WB, Dharmarajan K, Ting H, Krumholz HM, Nasir K. Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013. The American Heart Association Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke
Likosky DS, Van Parys J, Zhou W, Borden WB, Weinstein MC, Skinner JS. Association Between Medicare Expenditure Growth and Mortality Rates in Patients with Acute Myocardial Infarction: A Comparison From 1999 Through 2014. JAMA Cardiol. 2017 Dec 20. doi:10.1001/jamacardio.2017.4771.
Farmer SA, Borden WB. Caution is Needed in Designing Pharmacy Coverage. J Am Heart Assoc. 2016. Nov 11;5(11). pii: e004466.
Chee TT, Ryan AM, Wasfy JH, Borden WB. Current State of Value-Based Purchasing Programs. Circulation. 2016;133:2197-2205
Borden WB, Marier AF, Dennison TH, Freund DA, Cook K, Mushlin AI. Assessing Variation in Utilization for Acute Myocardial Infarction in New York State. Healthcare (2014), http://dx.doi.org/10.1016/j.hjdsi.2014.05.001i.
Ryan AM, Burgess JF, Pesko M, Borden WB, Dimick J. The Early Effects of Medicare's Mandatory Hospital Pay-for-Performance Program. Health Serv Res. 2014. doi: 10.1111/1475-6773.12206.
Goyal P, Igel LI, LaScalea K, Borden WB. Cardiometabolic Impact of Non-Statin Lipid Lowering Therapies. Curr Atheroscler Rep. 2014 Feb;16(2):390. doi:10.1007/s11883-013-0390-0.
Deaño RC, Pandya A, Jones EC, Borden WB. A Look at Statin Cost-Effectiveness in View of the 2013 ACC/AHA Cholesterol Management Guidelines. Curr Atheroscler Rep. 2014 Jul;16:438. doi: 10.1007/s11883-014-0438-9.
Borden WB, Spertus JA, Mushlin AI, Roe MT, McCoy LA, Redberg RF. Antianginal Therapy Before Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2013 Aug 6; doi: 10.1161/circinterventions.112.000215
Likosky DS, Zhou W, Malenka DJ, Borden WB, Nallamothu BK, Skinner JS. Growth in Medicare Expenditures for Patients With Acute Myocardial Infarction: A Comparison of 1998 through 1999 and 2008. JAMA Intern Med; doi: 10.1001/jamainternmed.2013.10789
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6-e245.
Borden WB, Nallamothu BK. The new US Healthcare Law: An overview of the US Patient Protection and Affordable Care Act of 2010. Eur Heart J. 2013. doi:10.1093/eurheartj/eht455.
Smolderen KG, Spertus JA, Tang F, Oetgen W, Borden WB, Ting HH, Chan PS. Treatment Differences by Health Insurance Among Outpatients with Coronary Artery Disease: Insights from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2013 Jan 25; doi: 10.1016/j.jacc.2012.11.058.
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.